


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-10.91%
+9.98%
-2.35%
-4.15%
+9.30%
CRON
Cronos Group
$3.13
Risk Analysis

Downgraded on weak valued
CRON Price Performance
$2.45 (+27.76%)
$2.67 (+17.23%)
$2.09 (+49.76%)
$2.01 (+55.72%)
CRON has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Price under $5

CRON overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Revenue increase YoY
Rating
Rating

Downgraded on weak valued
Momentum
Momentum
Activity
Activity
Future
Future
![]()
CRON Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
CRON Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels
Login to displayWhat is CRON current stock price?
What are CRON stock strengths?
What is CRON Risk Level?
What is CRON market cap and volume?
What is CRON current Stock IQ?
Should I buy CRON stock right now?
Is CRON a Strong Buy right now?
What does a 'Strong Buy' rating mean for CRON?
What does a 'Strong Sell' rating mean for CRON?
What factors influence CRON's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-10.91%
+9.98%
-2.35%
-4.15%
+9.30%
CRON
Cronos Group
Current Price
$3.13
Stock Insights
Risk Analysis

Downgraded on weak valued

CRON Price Performance
$2.45 (+27.76%)
$2.67 (+17.23%)
$2.09 (+49.76%)
$2.01 (+55.72%)
CRON Analysts Opinion
CRON Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Revenue increase YoY
Rating
Rating

Downgraded on weak valued
Momentum
Momentum
Activity
Activity
Future
Future
![]()
CRON Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
CRON Street Sentiment is extremely bullish and have positive views on the near-term outlook
CRON has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Price under $5

Average key support and resistance price levels
CRON Stock IQ
CRON Latest Analysis
Cronos (CRON) Set to Expand to the Netherlands With the Acquisition of Europes Largest Adult-Use Cannabis Company. Cronos Group Inc. (NASDAQ:CRON) is one of the best long-term penny stocks to invest in. Cronos Group Inc. (NASDAQ:CRON) announced on December 9 that its wholly-owned subsidiary entered into a definitive share sale and purchase agreement for the acquisition of all the outstanding shares of CanAdelaar B.V. which is the largest cannabis company in operation [….]
Today
Cronos Group Plans Strategic Europe Expansion: How to Play the Stock?. CRONs planned CanAdelaar acquisition boosts its push into the Dutch adult-use cannabis market and highlights its strengthening international momentum.
Wed Dec 10, 2025
Cronos Group (CRON) Goes 7.6% High on Cannabis Expansion in Europe. We recently published Small But Savage: 10 Stocks Delivering Outsized Gains. Cronos Group Inc. (NASDAQ:CRON) is one of the best performers on Tuesday. Cronos Group jumped by 7.56 percent on Tuesday to finish at $2.69 apiece as investor sentiment was fueled by its cannabis expansion program with the full acquisition of a European company. In [….]
Wed Dec 10, 2025
Cronos to enter the Netherlands with acquisition of Europes largest adult-use cannabis company. Cronos to acquire CanAdelaar for up-front cash consideration of US$67.0M1 plus cash earnout of 0.5x normalized EBITDA in 2026 and 2027
Tue Dec 9, 2025
Crypto.com and 21shares Announce Strategic Partnership to Expand Access to the Cronos Ecosystem. Partnership to enable launch of new investment products tracking the Cronos (CRO) token
Mon Dec 8, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
CRON Stock trends
CRON Stock performance
CRON Stock analysis
CRON investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.